Resources
- FAQ
- Protocol
- Cell Culture Guide
- Technical Bulletins
-
Explore & Learn
-
Cell Biology
- How to Handle Mycoplasma in Cell Culture?
- Enrichment, Isolation and Characterization of Circulating Tumor Cells (CTCs)
- Strategies for Enrichment of Circulating Tumor Cells (CTCs)
- How to Assess the Migratory and Invasive Capacity of Cells?
- Multi-Differentiation of Peripheral Blood Mononuclear Cells
- Monocytes vs. Macrophages
- How to Detect and Remove Endotoxins in Biologics?
- Comparison of Different Methods to Measure Cell Viability
- How to Isolate PBMCs from Whole Blood?
- CHO Cell Line Development
- How to Isolate and Analyze Tumor-Infiltrating Leukocytes?
- Generation and Applications of Neural Stem Cells
- Stem Cell Markers
- Comparison of the MSCs from Different Sources
- Troubleshooting Cell Culture Contamination: A Comprehensive Guide
- Tips For Cell Cryopreservation
- What Cell Lines Are Commonly Used in Biopharmaceutical Production?
- T Cell Activation and Expansion
- Mesenchymal Stem Cells: A Comprehensive Exploration
- What are the Differences Between M1 and M2 Macrophages?
- Organoid Differentiation from Induced Pluripotent Stem Cells
- Quantification of Cytokines
- IL-12 Family Cytokines and Their Immune Functions
- What are Mesothelial Cells?
- How to Scale Up Single-Cell Clones?
- STR Profiling—The ID Card of Cell Line
- Comparison of Several Techniques for the Detection of Apoptotic Cells
- Contamination of Cell Cultures & Treatment
- Cell Culture Medium
- What Are Myeloid Cell Markers?
- Cryopreservation of Cells Step by Step
- Cell Cryopreservation Techniques and Practices
- Human Primary Cells: Definition, Assay, Applications
- How to Eliminate Mycoplasma From Cell Cultures?
- Critical Quality Attributes and Assays for Induced Pluripotent Stem Cells
- Major Problems Caused by the Use of Uncharacterized Cell Lines
- T Cell, NK Cell Differentiation from Induced Pluripotent Stem Cells
- Direct vs. Indirect Cell-Based ELISA
- What Is Cell Proliferation and How to Analyze It?
- Unveiling the Molecular Secrets of Adipogenesis in MSCs
- How to Decide Between 2D and 3D Cell Cultures?
- Neural Differentiation from Induced Pluripotent Stem Cells
- Isolation, Expansion, and Analysis of Natural Killer Cells
- Tumor Stem Cells: Identification, Isolation and Therapeutic Interventions
- What are PBMCs?
- How to Start Your Culture: Thawing Frozen Cells
- Techniques for Cell Separation
- Biomarkers and Signaling Pathways in Tumor Stem Cells
- Circulating Tumor Cells as Cancer Biomarkers in the Clinic
- CFU Assay for Hematopoietic Cell
- Guidelines for Cell Banking to Ensure the Safety of Biologics
- Optimization Strategies of Cell-Based Assays
- Immunogenicity Testing: ELISA and MSD Assays
- 3D-Cell Model in Cell-Based Assay
- Types of Cell Therapy for Cancer
- From Collection to Cure: How ACT Works in Cancer Immunotherapy
- How to Maximize Efficiency in Cell-Based High-Throughput Screening?
- Cell-Based High-Throughput Screening Techniques
- What Are CAR T Cells?
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- Understanding Immunogenicity Assays: A Comprehensive Guide
- 3D-Cell Model in Cell-Based Assay
- Role of Cell-Based Assays in Drug Discovery and Development
- Immunogenicity Testing: ELISA and MSD Assays
- Optimization Strategies of Cell-Based Assays
- Adherent and Suspension Cell Culture
- Organoid Drug Screening
- Key Techniques in Primary, Immortalized and Stable Cell Line Development
- From Primary to Immortalized: Navigating Key Cell Lines in Biomedical Research
- From Specimen to Slide: Core Methods in Histological Practice
- Modern Histological Techniques
- Overview of Cell Apoptosis Assays
- Histological Staining Techniques: From Traditional Chemical Staining to Immunohistochemistry
- Mastering Cell Culture and Cryopreservation: Key Strategies for Optimal Cell Viability and Stability
- Exploring Cell Dynamics: Migration, Invasion, Adhesion, Angiogenesis, and EMT Assays
- Cell Viability, Proliferation and Cytotoxicity Assays
-
Histology
- Multiple Animal Tissue Arrays
- Tips for Choosing the Right Protease Inhibitor
- Instructions for Tumour Tissue Collection, Storage and Dissociation
- Troubleshooting in Fluorescent Staining
- Fluorescent Nuclear Staining Dyes
- Stains Used in Histology
- Guides for Live Cell Imaging Dyes
- Overview of the FFPE Cell Pellet Product Lines
- Immunohistochemistry Troubleshooting
- Cell and Tissue Fixation
- Cell Lysates: Composition, Properties, and Preparation
- Microscope Platforms
- Mitochondrial Staining
- How to Apply NGS Technologies to FFPE Tissues?
- Overview of Common Tracking Labels for MSCs
- Immunohistochemistry Controls
- Comparison of Membrane Stains vs. Cell Surface Stains
-
Exosome
- Exosomes as Emerging Biomarker Tools for Diseases
- How to Apply Exosomes in Clinical?
- How to Efficiently Utilize MSC Exosomes for Disease Treatment?
- What's the Potential of PELN in Disease Treatment?
- Emerging Technologies and Methodologies for Exosome Research
- Summary of Approaches for Loading Cargo into Exosomes
- How to Perform Targeted Modification of Exosomes?
- How to Enhancement Exosome Production?
- How to characterize exosomes?
- How to Label Exosomes?
- Classification, Isolation Techniques and Characterization of Exosomes
- Exosome Quality Control: How to Do It?
- The Role of Exosomes in Cancer
- Techniques for Exosome Quantification
- Exosome Size Measurement
- What are the Functions of Exosomal Proteins?
- Applications of MSC-EVs in Immune Regulation and Regeneration
- Unraveling Biogenesis and Composition of Exosomes
- Production of Exosomes: Human Cell Lines and Cultivation Modes
- Exosome Transfection for Altering Biomolecular Delivery
- How do PELN Deliver Drugs?
- Current Research Status of Milk Exosomes
- Collection of Exosome Samples and Precautions
- How Important are Lipids in Exosome Composition and Biogenesis?
- Exosome Antibodies
- Common Techniques for Exosome Nucleic Acid Extraction
-
ISH/FISH
- What Types of Multicolor FISH Probe Sets Are Available?
- What Is the Use of FISH in Solid Tumors?
- Mapping of Transgenes by FISH
- Reagents Used in FISH Experiments
- ISH probe labeling method
- Telomere Length Measurement Methods
- FISH Tips and Troubleshooting
- Comprehensive Comparison of IHC, CISH, and FISH Techniques
- Multiple Approaches to Karyotyping
- RNAscope ISH Technology
- CARD-FISH: Illuminating Microbial Diversity
- What are the Differences between FISH, aCGH, and NGS?
- Overview of Oligo-FISH Technology
- Differences Between DNA and RNA Probes
- Comparative Genomic Hybridization and Its Applications
- Small RNA Detection by ISH Methods
- Multiple Options for Proving Monoclonality
- FISH Techniques for Biofilm Detection
- Whole Chromosome Painting Probes for FISH
- Guidelines for the Design of FISH Probes
- How to Use FISH in Hematologic Neoplasms?
- Different Types of FISH Probes for Oncology Research
- In Situ Hybridization Probes
- Overview of Common FISH Techniques
- What are Single, Dual, and Multiplex ISH?
-
Toxicokinetics & Pharmacokinetics
- How to Improve Drug Plasma Stability?
- What Are Metabolism-Mediated Drug-Drug Interactions?
- Pharmacokinetics of Therapeutic Peptides
- How Is the Cytotoxicity of Drugs Determined?
- How to Improve the Pharmacokinetic Properties of Peptides?
- Toxicokinetics vs. Pharmacokinetics
- Organoids in Drug Discovery: Revolutionizing Therapeutic Research
- Experimental Methods for Identifying Drug-Drug Interactions
- Organ-on-a-Chip Systems for Drug Screening
- Key Considerations in Toxicokinetic
- Pharmacokinetics Considerations for Antibody Drug Conjugates
- Methods of Parallel Artificial Membrane Permeability Assays
- How to Conduct a Bioavailability Assessment?
- Overview of In Vitro Permeability Assays
- Traditional vs. Novel Drug Delivery Methods
- Predictive Modeling of Metabolic Drug Toxicity
- The Rise of In Vitro Testing in Drug Development
- What Are Compartment Models in Pharmacokinetics?
- Comparison of MDCK-MDR1 and Caco-2 Cell-Based Permeability Assays
- What factors influence drug distribution?
- How to Design and Synthesize Antibody Drug Conjugates?
- Key Factors Influencing Brain Distribution of Drugs
- What Is the Role of the Blood-Brain Barrier in Drug Delivery?
- Parameters of Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion
- What are the Pharmacokinetic Properties of the Antisense Oligonucleotides?
- Effects of Cytochrome P450 Metabolism on Drug Interactions
- How to Improve Drug Distribution in the Brain
- Physical and Chemical Properties of Drugs and Calculations
- Unraveling the Role of hERG Channels in Drug Safety
-
Disease Models
- What Human Disease Models Are Available for Drug Development?
- Preclinical Models of Acute Liver Failure
- Overview of Cardiovascular Disease Models in Drug Discovery
- Summary of Advantages and Limitations of Different Oncology Animal Models
- Why Use PDX Models for Cancer Research?
- Disease Models of Diabetes Mellitus
- Animal Models of Neurodegenerative Diseases
-
Cell Biology
- Life Science Articles
- Download Center
- Trending Newsletter
Immunocytochemistry (ICC) Protocol
GUIDELINE
Immunocytochemistry is a new technique for the qualitative, localized and quantitative determination of the corresponding antigens through antigen-antibody reactions and histochemical colorimetric reactions in tissue cells in situ with specific antibodies labeled with chromogenic agents. It skillfully combines the specificity of immune reaction and the visibility of histochemistry, and detects various antigenic substances (such as proteins, peptides, enzymes, hormones, pathogens and receptors) at the cellular and subcellular levels with the help of the visualization and magnification of microscopes (including fluorescent microscopes and electron microscopes).
METHODS
- Fixation. Fix samples in cold methanol, acetone for 1-10 minutes or PBS containing 3-4% paraformaldehyde pH 7.4 for 15 minutes at room temperature. Then, rinse samples twice with cold PBS.
- Permeability. Incubate samples in PBS containing 0.25% Triton X-100 (or 100 μM digitalis saponin or 0.5% saponin) for 10 minutes. Rinse cells with PBS for 3 × 5 minutes.
- Blocking and incubation. Cells are incubated in PBST with 1% BSA for 30 minutes to block non-specific binding of the antibody. Cells are co-incubated with antibody (diluted in 1% BSA in PBST) in a wet box for 1 hour at room temperature, or overnight at 4°C. Discard the liquid and rinse the cells with PBS for 3 × 5 minutes. Cells are incubated with secondary antibody in 1% BSA for 1 hour at room temperature, protected from light. Discard secondary antibody solution and rinse cells with PBS for 3 × 5 minutes, protected from light.
- Re-stain. 0.1-1 μg/ml Hoechst or DAPI (DNA stain) incubate cells for 1 min. then, rinse with PBS.
- Sealing. Add a drop of sealing solution to the coverslip to seal it. Seal the coverslip with nail polish to prevent it from drying out and move it to the microscope for observation. Store at -20 °C or 4 °C away from light.
NOTES
- Pre-incubation of the sample with 5% BSA for 10 min. prior to the primary antibody reaction may decrease background staining. For best results with animal tissues, use 5 to 10% normal serum from the same species as the host of the secondary antibody.
- Optimal dilution and incubation times should be determined for each primary antibody prior to use.
- When using AEC substrate, do not use alcohol-containing solutions for counter-staining (e.g., Harris' hematoxylin, acid alcohol), since the AEC stain formed by this method is soluble in organic solvents. The slide must not be dehydrated, brought back to toluene (or xylene), or mounted in toluene-containing mountants.
RELATED PRODUCTS & SERVICES
For research use only. Not for any other purpose.